RecruitingPhase 2Phase 3NCT06731764

Novel Approaches to the Treatment of Hypothyroidism


Sponsor

UConn Health

Enrollment

90 participants

Start Date

Dec 10, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Hypothyroidism is a common condition, more frequent in females, associated with excess of cardiovascular risk and poor quality of life not completely abrogated by treatment with levothyroxine. There is an unmet need to define a safe, effective, and feasible regimen to be applied in large trials aimed at assessing levothyroxine/liothyronine combination therapy in patients living with hypothyroidism. To address this knowledge gap we propose a randomized, three-arm, double-blind, controlled, escalating dose parallel pilot study whose results will lay the foundation of large multicenter trial(s) able to demonstrate the effectiveness (or lack thereof) of levothyroxine/liothyronine combination therapy.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Levothyroxine, a drug called Levothyroxine/Liothyronine once daily, and others for people with hypothyroidism. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLevothyroxine

Patients will receive Levothyroxine/Placebo Levothyroxine/Liothyronine with Liothyronine administered twice daily.

DRUGLevothyroxine/Liothyronine once daily

Patients will receive Levothyroxine/Liothyronine with Liothyronine administered once daily;

DRUGLevothyroxine/Liothyronine twice daily

Patients will receive Levothyroxine/Liothyronine with Liothyronine administered twice daily;


Locations(1)

UConn Health

Farmington, Connecticut, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06731764


Related Trials